Aegon AGN.AS
Aegon is a diversified insurer headquartered in the Netherlands, offering life insurance, pensions, and asset management, with a growing focus on the US market through its Transamerica subsidiary. Aegon presents an attractive valuation (P/E 12.08, forward 8.49) and a solid dividend (net yield 5.35%), but its financial health is weighed down by a very low ROA (0.10%) and negative revenue growth (-8.20%). The success of the Transamerica restructuring and synergies from the Standard Life deal are key to its future.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Aegon is a diversified insurer headquartered in the Netherlands, offering life insurance, pensions, and asset management, with a growing focus on the US market through its Transamerica subsidiary. Aegon presents an attractive valuation (P/E 12.08, forward 8.49) and a solid dividend (net yield 5.35%), but its financial health is weighed down by a very low ROA (0.10%) and negative revenue growth (-8.20%). The success of the Transamerica restructuring and synergies from the Standard Life deal are key to its future.
Score by category
| Category | Score |
|---|---|
| Financial health | 3.9 |
| Quality / Moat | 4.0 |
| Valuation | 6.0 |
| Growth | 3.9 |
| Dividend | 8.5 |
| Momentum | 6.9 |
| Risk & Context | 8.2 |
OVERALL SCORE: 5.8/10
Context and risks
The macro interest rate context is relevant for the insurance sector, but Aegon does not show material exposure to the specific factors mentioned (oil, geopolitics, AI). Its life insurance and asset management business is less sensitive to these shocks than other sectors.
News considered in the analysis
- Standard Life continues cost-cutting and eyes £800m ‘synergies’ from Aegon deal — Las sinergias de 800 millones de libras del acuerdo con Standard Life son materiales y podrían impulsar significativamente los beneficios futuros, aunque su materialización aún no está garantizada.
- Aegon (AEG) Expanded its Buyback After a Capital Beat. Is the Transamerica Pivot Working? — La expansión del programa de recompra tras superar las expectativas de capital es una señal positiva de gestión de capital, aunque el mercado ya lo ha descontado parcialmente.
- EG Stock Trading at a Discount to Industry at 0.92X: Time to Hold? — Artículo de opinión genérico sobre valoración relativa, sin información nueva.
- Aegon (ENXTAM:AGN), What Is Drawing Fresh Attention To The Insurer? — Artículo superficial sin datos concretos que afecten a la valoración.
- New Strong Sell Stocks for September 21st — Listado genérico de recomendaciones de venta, sin análisis específico para Aegon.
Verdict: Hold, pending the materialization of synergies from the Standard Life deal and an improvement in revenue growth.
Main risk: The main risk is the execution of the Transamerica restructuring and the integration of the Standard Life deal; if synergies fail to materialize or revenue growth remains negative, the attractive valuation could be a value trap.
Other Financial Services companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →